Delayed immune-related adverse events in assessment for dose-limiting toxicity in early phase immunotherapy trials

Autor: Kanjanapan, Y., Day, D., Butler, M.O., Wang, L., Joshua, A.M., Hogg, D., Leighl, N.B., Razak, A.R. Abdul, Hansen, A.R., Boujos, S., Chappell, M., Chow, K., Sherwin, B., Stayner, L.-A., Soultani, L., Zambrana, A., Siu, L.L., Bedard, P.L., Spreafico, A.
Zdroj: In European Journal of Cancer January 2019 107:1-7
Databáze: ScienceDirect